Literature DB >> 17921984

The FDA animal efficacy rule and biodefense.

Gigi Kwik Gronvall, Dennis Trent, Luciana Borio, Robert Brey, Lee Nagao.   

Abstract

Mesh：

Year:  2007        PMID： 17921984     DOI： 10.1038/nbt1007-1084

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  22 in total

1.  Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys.

Authors:  Rafal J Zielinski; Jeremy V Smedley; Pin-Yu Perera; Peter M Silvera; Thomas A Waldmann; Jacek Capala; Liyanage P Perera
Journal:  Vaccine       Date:  2010-08-20       Impact factor: 3.641

2.  Particle-to-PFU ratio of Ebola virus influences disease course and survival in cynomolgus macaques.

Authors:  Kendra J Alfson; Laura E Avena; Michael W Beadles; Hilary Staples; Jerritt W Nunneley; Anysha Ticer; Edward J Dick; Michael A Owston; Christopher Reed; Jean L Patterson; Ricardo Carrion; Anthony Griffiths
Journal:  J Virol       Date:  2015-07       Impact factor: 5.103

3.  Comprehensive analysis and selection of anthrax vaccine adsorbed immune correlates of protection in rhesus macaques.

Authors:  Ligong Chen; Jarad M Schiffer; Shannon Dalton; Carol L Sabourin; Nancy A Niemuth; Brian D Plikaytis; Conrad P Quinn
Journal:  Clin Vaccine Immunol       Date:  2014-09-03

4.  Anthrax vaccine-induced antibodies provide cross-species prediction of survival to aerosol challenge.

Authors:  Michael P Fay; Dean A Follmann; Freyja Lynn; Jarad M Schiffer; Gregory V Stark; Robert Kohberger; Conrad P Quinn; Edwin O Nuzum
Journal:  Sci Transl Med       Date:  2012-09-12       Impact factor: 17.956

Review 5.  Improving the predictive value of interventional animal models data.

Authors:  Caroline J Zeiss
Journal:  Drug Discov Today       Date:  2014-11-04       Impact factor: 7.851

6.  Cross-species prediction of human survival probabilities for accelerated anthrax vaccine absorbed (AVA) regimens and the potential for vaccine and antibiotic dose sparing.

Authors:  G V Stark; G S Sivko; M VanRaden; J Schiffer; K L Taylor; J A Hewitt; C P Quinn; E O Nuzum
Journal:  Vaccine       Date:  2016-08-22       Impact factor: 3.641

7.  Using biomarkers to stage disease progression in a lethal mousepox model treated with CMX001.

Authors:  Scott Parker; Jill Schriewer; Christina Oberle; Alice Robertson; Randall Lanier; George Painter; R Mark Buller
Journal:  Antivir Ther       Date:  2008

Review 8.  Biological and medical applications of a brain-on-a-chip.

Authors:  David Pamies; Thomas Hartung; Helena T Hogberg
Journal:  Exp Biol Med (Maywood)       Date:  2014-06-09

9.  Ectromelia virus infections of mice as a model to support the licensure of anti-orthopoxvirus therapeutics.

Authors:  Scott Parker; Akbar M Siddiqui; George Painter; Jill Schriewer; R Mark Buller
Journal:  Viruses       Date:  2010-09-03       Impact factor: 5.818

Review 10.  Transboundary Animal Diseases, an Overview of 17 Diseases with Potential for Global Spread and Serious Consequences.

Authors:  Elizabeth A Clemmons; Kendra J Alfson; John W Dutton
Journal:  Animals (Basel)       Date:  2021-07-08       Impact factor: 2.752
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.